# Business Genome Compiler v1.0 Known Limitations

**Release:** v1.0.0-business-genome-compiler  
**Branch:** release/business-genome-compiler-v1  
**Date:** 2026-07-12

---

## Overview

This document catalogs known limitations in Business Genome Compiler v1.0. These are intentional design decisions, pre-existing infrastructure gaps, or features deferred to future releases.

**Important**: None of these limitations block v1.0.0 release, but they should inform deployment planning and Phase 2-4 roadmap.

---

## Category 1: Architecture & Design Limitations

### 1.1 Non-Modification Guarantee (By Design)

**Description**: The compiler explicitly guarantees it will NEVER modify the Business Genome Graph structure, even when repair would improve quality.

**Impact**: 
- Invalid graphs remain invalid
- Validation failures cannot be auto-corrected
- Users must fix upstream Evidence IR issues

**Examples of Intentional Non-Modifications**:
- Graph missing nodes → Not synthesized
- Invalid semantic relationships → Not repaired
- Conflicting evidence → Not resolved
- Identity reassignment → Not performed

**Remediation**: None (this is a feature, not a bug)  
**Status**: Working as designed ✓

### 1.2 Single-Threaded Execution

**Description**: Compiler designed for single-threaded, sequential pass execution.

**Impact**:
- Thread safety not guaranteed
- Concurrent compilation not supported
- Each compilation must be isolated

**Typical Usage Pattern**:
```typescript
const compiler = new BusinessGenomeCompiler();
const result1 = compiler.compile(input1); // OK
const result2 = compiler.compile(input2); // OK
// But NOT: Promise.all([compiler.compile(input1), compiler.compile(input2)])
```

**Remediation**: Create separate compiler instances for parallel processing  
**Timeline**: Optional optimization for v2.0  
**Status**: Documented limitation

### 1.3 No Runtime Dynamic Pass Registration

**Description**: All compiler passes must be registered at compile-time via BusinessGenomePassRegistry.

**Impact**:
- Cannot add custom passes at runtime
- Cannot selectively disable passes
- Cannot reorder passes dynamically

**Current Pattern**:
```typescript
// Passes registered statically in registerDefaultPasses()
private registerDefaultPasses(): void {
  this.register(new InputValidationPass());
  this.register(new CanonicalVerificationPass());
  // ... all 11 passes registered here
}
```

**Remediation**: Implement dynamic pass registration interface in v1.1  
**Timeline**: Deferred to v1.1  
**Status**: Known gap

### 1.4 No Pass Ordering Override

**Description**: Pass execution order determined by topological sort of dependencies; cannot override.

**Impact**:
- Must use designed pass sequence
- Cannot skip passes
- Cannot reorder for optimization

**Rationale**: Pass ordering is critical for correctness; allowing overrides creates risk of invalid transformations

**Remediation**: Implement governance-controlled override capability in v1.1  
**Timeline**: Deferred to v1.1  
**Status**: Known gap

---

## Category 2: Testing & Validation Limitations

### 2.1 Test Fixtures Only, No Real Enterprise Data

**Description**: Compiler validated with synthetic test fixtures, not production discovery data.

**Impact**:
- Unknown behavior with scale/complexity of real enterprise data
- Real-world pattern variations not fully tested
- Performance characteristics not proven

**Test Fixtures Used**:
- Zach Anderson discovery interview (synthetic)
- Madison discovery interview (synthetic)
- Mock data builders for unit tests

**Remediation**: Phase 3-4 deployment with real SSI discovery data  
**Timeline**: Enterprise validation Phase 4  
**Status**: Planned validation activity

### 2.2 No Performance Benchmarks

**Description**: No defined performance requirements or measured benchmarks.

**Impact**:
- Unknown throughput (artifacts/second)
- Unknown memory consumption
- Unknown latency characteristics
- Unknown scalability limits

**Current State**:
- Compiler uses deterministic O(n log n) algorithms
- No load testing performed
- No performance profiling completed

**Remediation**: 
1. Define performance SLOs (v1.1)
2. Measure baseline performance (v1.1)
3. Optimize hot paths (v1.2+)

**Timeline**: v1.1 performance baseline  
**Status**: Deferred to v1.1

### 2.3 No Concurrency Testing

**Description**: Compiler not tested for thread-safe or concurrent execution.

**Impact**:
- Cannot guarantee behavior under concurrent load
- Race conditions not ruled out
- Lock-free algorithms not validated

**Current State**:
- Single-threaded execution only
- No concurrent test cases
- No load testing with parallel calls

**Remediation**: Document single-threaded requirement; add concurrency tests in v2.0  
**Timeline**: Optional optimization for v2.0  
**Status**: Known gap

### 2.4 Repository-Wide Test Baseline Issues

**Description**: Full `npm test` suite has pre-existing failures unrelated to compiler.

**Impact**:
- Cannot validate entire repository
- Compiler tests passing but obscured in noise
- CI/CD pipeline needs filtering

**Known Issues**:
- Template placeholder files have compilation errors
- Some test files use incompatible test framework syntax
- Baseline failures from modules unrelated to M1.11

**Compiler-Specific Status**: ✅ All M1.11 tests passing (41/41)  
**Remediation**: Fix unrelated tests in separate initiative  
**Timeline**: Ongoing separate effort  
**Status**: Documented baseline issue

### 2.5 Global TypeScript Compilation Issues

**Description**: Full `npx tsc --noEmit` fails due to template files; cannot perform global type-check.

**Impact**:
- No global TypeScript validation script
- Must use targeted pass-specific compilation checks
- Type safety not proven at repository level

**M1.11 Status**: ✅ Publication pass compiles cleanly (`npx tsc --noEmit src/compiler/genome/passes/BusinessGenomePublicationPass.ts`)

**Current Workaround**:
```bash
# Works:
npx tsc --noEmit src/compiler/genome/passes/BusinessGenomePublicationPass.ts

# Fails (template issues):
npx tsc --noEmit
```

**Remediation**: Modernize template files in separate initiative  
**Timeline**: Ongoing  
**Status**: Documented baseline issue

---

## Category 3: Specification & Governance Limitations

### 3.1 BGS/BGC Relationship Taxonomy Discrepancy

**Description**: Business Genome Schema (BGS-0001) and Business Genome Compiler (BGC-0001) use overlapping but not identical relationship class taxonomies.

**Impact**:
- Relationship resolution uses intersection of both taxonomies
- Some BGS relationship classes not recognized by compiler
- Some BGC relationship classes not in BGS-0001

**Current Relationship Classes** (Intersection):
```typescript
const BUSINESS_GENOME_RELATIONSHIP_CLASSES = [
  "association",
  "composition",
  "delegation",
  "containment",
  "lifecycle",
  "influence",
] as const;
```

**Governance Note** (From codebase):
```
M1.7 uses BGS-0001 and BGC-0001 shared relationship class intersection 
pending governance clarification.
```

**Remediation**: 
1. Unified BGS/BGC specification (Phase 2)
2. Governance review of relationship taxonomy (Phase 2)
3. Implementation update in M1.7 v1.1

**Timeline**: v1.1 after governance review  
**Status**: Pending architecture review

### 3.2 No Backward Compatibility Guarantees

**Description**: v1.0 artifacts may not be processable by v2.0 or later.

**Impact**:
- No migration path for v1.0 → v2.0
- No artifact versioning strategy defined
- v1.0 data may not be preserved

**Current State**:
- Artifacts versioned: `"1.0.0"`
- Schema versioned: `"1.0.0"`
- But no migration strategy for future versions

**Remediation**:
1. Define artifact versioning strategy (v1.1)
2. Implement artifact migration capability (v2.0)
3. Document breaking changes policy

**Timeline**: v1.1 strategy definition  
**Status**: Deferred to v1.1

### 3.3 No Custom Diagnostic Code Registration

**Description**: All diagnostic codes must be predefined in `BGC_DIAGNOSTIC_CODES` constant.

**Impact**:
- Cannot extend diagnostics at runtime
- Cannot add custom pass diagnostics
- Limited extensibility

**Current Diagnostic Codes** (10 for M1.11):
- BGC-PUB-001: VALIDATION_BLOCKS_PUBLICATION
- BGC-PUB-002: MISSING_GRAPH
- ... (8 more)

**Remediation**: Implement extensible diagnostic registry in v2.0  
**Timeline**: Optional enhancement for v2.0  
**Status**: Known gap

---

## Category 4: Feature Limitations (By Design)

### 4.1 Graph Modification Intentionally Prevented

**Description**: Compiler will NEVER modify the Business Genome Graph structure.

**Design Rationale**:
- Non-modification guarantee must be absolute
- Graph integrity must be preserved
- Transformation must be purely additive (artifacts) not modifying

**Cannot Do** (Intentionally):
- Add missing nodes
- Remove invalid nodes
- Repair relationships
- Reassign identities
- Consolidate nodes

**Rationale**: See requirement specification section 13 in engineering report

**Status**: Working as designed ✓

### 4.2 Validation Failures Cannot Be Auto-Repaired

**Description**: Compiler documents validation failures but never repairs them.

**Design Rationale**:
- Validation failures indicate upstream Evidence IR issues
- Auto-repair would mask data quality problems
- Transparent failure reporting is preferred

**Examples**:
- Missing canonical designation → Not synthesized
- Conflicting evidence → Preserved as-is, not resolved
- Invalid identity assignments → Not corrected

**User Responsibility**: Fix Evidence IR upstream

**Status**: Working as designed ✓

### 4.3 No Semantic Inference

**Description**: Compiler creates relationships only from explicit evidence, never infers.

**Design Rationale**:
- Enterprise governance requires explicit evidence
- No AI/ML in compiler core
- Determinism requires no probabilistic logic

**Cannot Do** (Intentionally):
- Infer missing relationships
- Suggest semantic objects
- Use fuzzy matching
- Apply machine learning

**Status**: Working as designed ✓

---

## Category 5: Extensibility Limitations

### 5.1 No Pluggable Evidence IR Importers in Compiler

**Description**: Evidence IR must be created by Discovery Engine; compiler accepts only pre-built IR.

**Impact**:
- Compiler cannot directly process PDFs, documents, etc.
- Must use separate Evidence IR creation pipeline
- No custom importer registration in compiler

**Current Architecture**:
```
Evidence IR (from Discovery Engine)
  ↓
Business Genome Compiler (v1.0)
  ↓
Business Genome Artifact
```

**Remediation**: Handled by Discovery Engine, not compiler  
**Status**: Architecture working as designed

### 5.2 No Custom Validation Rules

**Description**: Validation rules defined in M1.10 pass; cannot be extended at runtime.

**Impact**:
- Cannot add custom validation checks
- Cannot disable standard validations
- Fixed rule set for v1.0

**Current Validation Rules** (From ConsistencyValidationPass):
- Graph structure validation
- Node/edge completeness checks
- Identity assignment validation
- Provenance reference validation

**Remediation**: Implement pluggable validation in v2.0  
**Timeline**: Optional enhancement for v2.0  
**Status**: Known gap

### 5.3 No Business Logic Customization

**Description**: Business logic (consolidation rules, relationship rules) is fixed for v1.0.

**Impact**:
- Cannot tune consolidation behavior
- Cannot customize relationship matching
- Fixed business rules

**Current Rules** (Examples):
- Semantic consolidation: Identical class + identical designation = merge
- Relationship resolution: Evidence-backed relationships only

**Remediation**: Governance-controlled rule customization in v1.1  
**Timeline**: v1.1 with governance review  
**Status**: Deferred

---

## Category 6: Deployment & Operations Limitations

### 6.1 No Deployment Validation Performed

**Description**: Compiler not deployed or validated in production environments.

**Impact**:
- Unknown real-world reliability
- Unknown failure modes in production
- Unknown operational characteristics

**Current State**: Tested only in development environment

**Remediation**: Phase 4 production deployment and validation  
**Timeline**: Phase 4  
**Status**: Planned validation

### 6.2 No Monitoring/Observability Infrastructure

**Description**: No built-in monitoring, logging, or observability for compiler operations.

**Impact**:
- Cannot track compilation performance
- Cannot debug production issues
- Cannot collect metrics

**Current State**:
- Diagnostics available in result
- No external metrics/logging
- No structured observability

**Remediation**: Add observability layer in v1.1  
**Timeline**: v1.1  
**Status**: Deferred

### 6.3 No Graceful Degradation

**Description**: Compiler operates in all-or-nothing mode; cannot produce partial results.

**Impact**:
- If any pass fails, entire compilation fails
- No recovery mechanisms
- No fallback modes

**Current Behavior**:
```
Compiler.compile() → Intermediate | Failed
(binary success/failure, no partial state)
```

**Remediation**: Optional graceful degradation in v2.0  
**Timeline**: v2.0  
**Status**: Known gap

---

## Category 7: Data & Integration Limitations

### 7.1 No Evidence IR Transformation Guarantees

**Description**: Compiler assumes Evidence IR is structurally valid; does not verify IR schema compliance.

**Impact**:
- Upstream IR validation is prerequisite
- Cannot handle malformed Evidence IR
- Garbage in → unexpected behavior

**Current Validation** (M1.1):
- Checks required fields present
- Does not validate Evidence IR schema compliance
- Assumes IR is well-formed

**Remediation**: Strengthen Evidence IR validation in M1.1 v1.1  
**Timeline**: v1.1  
**Status**: Known gap

### 7.2 No Enterprise Blueprint Compiler Integration

**Description**: EBC interface not defined; artifact format compatible but integration path unclear.

**Impact**:
- Unknown how EBC will consume artifacts
- Unknown artifact format requirements for EBC
- No integration tests

**Current State**:
- Artifact format designed
- EBC not yet implemented
- Integration contract pending

**Remediation**: Define EBC input contract before Phase 3  
**Timeline**: Phase 2  
**Status**: Planned before EBC implementation

### 7.3 No Artifact Repository/Registry

**Description**: No built-in mechanism to store, retrieve, or catalog artifacts.

**Impact**:
- Artifacts must be managed externally
- No artifact versioning at storage layer
- No deduplication or caching

**Current Pattern**:
```typescript
// Create artifact
const artifact = compiler.compile(input);

// Store externally (user responsibility)
await storage.save(artifact.artifactIdentity, artifact);
```

**Remediation**: Implement artifact registry in Phase 3-4  
**Timeline**: Phase 3-4  
**Status**: Deferred

---

## Category 8: Future Work & Roadmap

### 8.1 Performance Optimization

**Not Addressed in v1.0**:
- Hot path optimization
- Memory efficiency improvements
- Parallel pass execution
- Streaming/incremental compilation

**Timeline**: v1.1+ post-baseline measurements

### 8.2 Enterprise Scale Validation

**Not Addressed in v1.0**:
- Real enterprise data processing
- Scale testing (100k+ nodes, 1M+ edges)
- Concurrency under load
- 24/7 operational validation

**Timeline**: Phase 4

### 8.3 Advanced Governance

**Not Addressed in v1.0**:
- Dynamic pass registration
- Custom business rule engine
- Pluggable validation rules
- Runtime configuration

**Timeline**: v1.1+

---

## Summary Table

| Category | Limitation | Severity | Timeline | Status |
|----------|-----------|----------|----------|--------|
| Design | Non-modification guarantee | By design | N/A | ✓ Working |
| Design | Single-threaded execution | Medium | v2.0 | Known |
| Design | No dynamic pass registration | Low | v1.1 | Gap |
| Testing | Real enterprise data | High | Phase 4 | Planned |
| Testing | Performance benchmarks | Medium | v1.1 | Gap |
| Testing | Concurrency testing | Medium | v2.0 | Gap |
| Testing | Global typecheck | Medium | Ongoing | Gap |
| Governance | BGS/BGC taxonomy | Medium | v1.1 | Review needed |
| Governance | Backward compatibility | Medium | v1.1 | Gap |
| Features | Graph modification | By design | N/A | ✓ Working |
| Features | Validation repair | By design | N/A | ✓ Working |
| Features | Semantic inference | By design | N/A | ✓ Working |
| Extensibility | Custom importers | N/A | Discovery Engine | External |
| Extensibility | Custom validation | Low | v2.0 | Gap |
| Deployment | Production validation | High | Phase 4 | Planned |
| Deployment | Monitoring/observability | Medium | v1.1 | Gap |
| Integration | EBC contract | Medium | Phase 2 | Pending |
| Integration | Artifact registry | Medium | Phase 3 | Gap |

---

## Conclusion

Business Genome Compiler v1.0 has well-documented, manageable limitations. None block the v1.0.0 release or Phase 2-4 roadmap. Most limitations are deferred enhancements rather than critical gaps.

**Key Points**:
1. ✅ Core compiler functionality complete and verified
2. ⚠️ Performance and scale untested (plan for Phase 4)
3. ⚠️ Some extensibility features deferred to v1.1+
4. ✅ All limitations documented and planned

---

*Document Generated: 2026-07-12*  
*Version: 1.0*  
*Status: COMPLETE*
